645 results on '"Shivkumar, K"'
Search Results
102. Patient -- heal thyself? Electrophysiology meets alternative medicine.
- Author
-
Olshansky B and Shivkumar K
- Published
- 2001
- Full Text
- View/download PDF
103. Mechanism of hypoxic K loss in rabbit ventricle
- Author
-
Shivkumar, K., Deutsch, N. A., Lamp, S. T., Khuu, K., Joshua Goldhaber, and Weiss, J. N.
104. Modeling and characterization of porous tantalum (Ta) scaffolds
- Author
-
Golla, B. R., Mamidi, S. K., Raja, V., Ali, M., Ankit Yadav, Sarath Chandra, T. D., Shivkumar, K., and Mathew, M. T.
105. STUDPRO — An intelligent student's profiling application software to enable effective learn ability.
- Author
-
Kulkarni, D.G., Charantimath, P., and Shivkumar, K.
- Published
- 2010
- Full Text
- View/download PDF
106. In silico to in vivo: mutation-specific modeling of arrhythmia risk.
- Author
-
Mandapati R and Shivkumar K
- Published
- 2012
- Full Text
- View/download PDF
107. Mechanisms of arrhythmias: are we still 'learning while burning'?
- Author
-
Shivkumar K
- Published
- 2002
- Full Text
- View/download PDF
108. Images in cardiovascular medicine. Labile repolarization from "cell to bedside".
- Author
-
Shivkumar, K
- Published
- 2000
109. Pleuropericardial fistula formation after prior epicardial catheter ablation for ventricular tachycardia.
- Author
-
Mathuria N, Buch E, and Shivkumar K
- Published
- 2012
- Full Text
- View/download PDF
110. Successful ablation of an epicardial ventricular tachycardia using a surgical ablation tool.
- Author
-
Mathuria NS, Vaseghi M, Buch E, and Shivkumar K
- Published
- 2011
- Full Text
- View/download PDF
111. Catheter ablation of ventricular tachycardia.
- Author
-
Tung R, Boyle NG, Shivkumar K, Tung, Roderick, Boyle, Noel G, and Shivkumar, Kalyanam
- Published
- 2010
- Full Text
- View/download PDF
112. Review: Early treatment of a cardiovascular event with nitrates or ACE inhibitors reduces short-term mortality.
- Author
-
Bradfield J, Shivkumar K, and Perez MI
- Published
- 2010
113. Re: Catheter ablation of right ventricular outflow tract.
- Author
-
Ho SY, Vaseghi M, and Shivkumar K
- Published
- 2006
114. MAGNETIC RESONANCE IMAGING PARAMETERS DO NOT PREDICT EARLY SUCCESS FOLLOWING CATHETER ABLATION OF ATRIAL FIBRILLATION.
- Author
-
Budge, D., Dinh, H. V., Valderrabano, M., Shivkumar, K., Ratib, O., and Finn, J. P.
- Published
- 2005
- Full Text
- View/download PDF
115. CARDIAC MRI.
- Author
-
Kaushal, R., Fieno, D., Radin, M., Shaoulian, E., Kadish, A., Narula, J., Goldberger, J., Shivkumar, K., and Bello, D.
- Published
- 2005
- Full Text
- View/download PDF
116. Carvedilol reduced mortality and morbidity caused by myocardial infarction in patients with left ventricular dysfunction.
- Author
-
Jagasia DH and Shivkumar K
- Published
- 2002
- Full Text
- View/download PDF
117. Toxic trace element pollution in ground waters around Patancheru andBolaram industrial areas, Andhra Pradesh, India: a graphical approach
- Author
-
Shivkumar, K., Biksham, G., and Pande, A. K.
- Subjects
TRACE elements ,GROUNDWATER monitoring - Abstract
Patancheru and Bolaram are satellite industrial towns near Hyderabadwith over 300 large and medium scale pharmaceutical, heavy engineering, paints, paper and chemical factories. The industries of the area generate a cumulative 8 x 10
6 l/day of effluents which arebeing directly discharged on to surrounding land, irrigation fields,and surface water bodies which finally enter into the Nakkavagu Rivera tributary of the Manzira River. The present study on abundance anddistribution pattern of toxic trace elements indicates the quantitative aspect of pollution in the Nakkavagu Basin. Migration patterns drawn for TDS, toxic elements such as Cu, As, Se, Zn, B, Cr and iron indicate that pollutants discharged by the industries are entering the surface and groundwater system (aquifers) and are also migrating towards the Manzira River further deteriorating the entire hydrological set of the area. Entry and dispersion of pollutants in the hydrological system is shown by distribution diagrams. A conservative estimate indicates that the effect of pollutants on the agricultural lands and water bodies extends 0.25 to 0.5 km to either side of the Nakkavagu River over a length of 25 km. In addition to this, the movement of pollutants with ground water in the downstream direction worsened the hydrological system and increased the possibility of geo-accumulation of pollutants in biota. Open wells, dug wells and tanks have become useless and redundant as the concentrations of Cu, Se, As, B, Cr and Fehave increased to 5 to 10 times the permissible limits. Several villages have been affected by the toxic pollutants in the area. The groundwater system is polluted over a large area as shown in elemental migration diagrams and is not potable. Tentatively an area of 20 sq km can be categorized as the worst affected by various pollutants. [ABSTRACT FROM AUTHOR]- Published
- 1997
- Full Text
- View/download PDF
118. Statistical approach for the assessment of water pollution around industrial areas: a case study from Patancheru, Medak District, India
- Author
-
Biksham, G. and Shivkumar, K.
- Subjects
POLLUTION ,RIVERS ,SEWAGE - Published
- 1995
119. Effects of Cyclic Flexion of Coronary Arteries on Progression of Atherosclerosis
- Author
-
Stein, P. D., Hamid, M. S., Shivkumar, K., and Davis, T. P.
- Published
- 1994
- Full Text
- View/download PDF
120. Characterization of the arrhythmogenic substrate in ischemic and nonischemic cardiomyopathy implications for catheter ablation of hemodynamically unstable ventricular tachycardia.
- Author
-
Nakahara S, Tung R, Ramirez RJ, Michowitz Y, Vaseghi M, Buch E, Gima J, Wiener I, Mahajan A, Boyle NG, Shivkumar K, Nakahara, Shiro, Tung, Roderick, Ramirez, Rafael J, Michowitz, Yoav, Vaseghi, Marmar, Buch, Eric, Gima, Jean, Wiener, Isaac, and Mahajan, Aman
- Abstract
Objectives: The purpose of this study was to compare the characteristics and prevalence of late potentials (LP) in patients with nonischemic cardiomyopathy (NICM) and ischemic cardiomyopathy (ICM) etiologies and evaluate their value as targets for catheter ablation.Background: LP are frequently found in post-myocardial infarction scars and are useful ablation targets. The relative prevalence and characteristics of LP in patients with NICM is not well understood.Methods: Thirty-three patients with structural heart disease (NICM, n = 16; ICM, n = 17) referred for catheter ablation of ventricular tachycardia were studied. Electroanatomic mapping was performed endocardially (n = 33) and epicardially (n = 19). The LP were defined as low voltage electrograms (<1.5 mV) with onset after the QRS interval. Very late potentials (vLP) were defined as electrograms with onset >100 ms after the QRS.Results: We sampled an average of 564 +/- 449 points and 726 +/- 483 points in the left ventricle endocardium and epicardium, respectively. Mean total low voltage area in patients with ICM was 101 +/- 55 cm(2) and 56 +/- 33 cm(2), endocardial and epicardial, respectively, compared with NICM of 55 +/- 41 cm(2) and 53 +/- 28 cm(2), respectively. Within the total low voltage area, vLP were observed more frequently in ICM than in NICM in endocardium (4.1% vs. 1.3%; p = 0.0003) and epicardium (4.3% vs. 2.1%, p = 0.035). An LP-targeted ablation strategy was effective in ICM patients (82% nonrecurrence at 12 +/- 10 months of follow-up), whereas NICM patients had less favorable outcomes (50% at 15 +/- 13 months of follow-up).Conclusions: The contribution of scar to the electrophysiological abnormalities targeted for ablation of unstable ventricular tachycardia differs between ICM and NICM. An approach incorporating LP ablation and pace-mapping had limited success in patients with NICM compared with ICM, and alternative ablation strategies should be considered. [ABSTRACT FROM AUTHOR]- Published
- 2010
- Full Text
- View/download PDF
121. Venice Chart International Consensus Document on Ventricular Tachycardia/Ventricular Fibrillation Ablation
- Author
-
Andrea, Natale, Antonio, Raviele, Amin, Al-Ahmad, Ottavio, Alfieri, Etienne, Aliot, Jesus, Almendral, Günter, Breithardt, Josep, Brugada, Hugh, Calkins, David, Callans, Riccardo, Cappato, John A, Camm, Paolo, Della Bella, Gerard M, Guiraudon, Michel, Haïssaguerre, Gerhard, Hindricks, Siew Yen, Ho, Karl H, Kuck, Francis, Marchlinski, Douglas L, Packer, Eric N, Prystowsky, Vivek Y, Reddy, Jeremy N, Ruskin, Mauricio, Scanavacca, Kalyanam, Shivkumar, Kyoko, Soejima, William J, Stevenson, Sakis, Themistoclakis, Atul, Verma, David, Wilber, Hiroshi, Nakagawa, Natale, A, Raviele, A, Al Ahmad, A, Alfieri, Ottavio, Aliot, E, Almendral, J, Breithardt, G, Brugada, J, Calkins, H, Callans, D, Cappato, R, Camm, Ja, Della Bella, P, Guiraudon, Gm, Haïssaguerre, M, Hindricks, G, Ho, Sy, Kuck, Kh, Marchlinski, F, Packer, Dl, Prystowsky, En, Reddy, Vy, Ruskin, Jn, Scanavacca, M, Shivkumar, K, Soejima, K, Stevenson, W. J, Themistoclakis, S, Verma, A, Wilber, D., Amsterdam Cardiovascular Sciences, and Pathology
- Subjects
medicine.medical_specialty ,Internationality ,business.industry ,education ,Medical school ,Care group ,University hospital ,humanities ,Physiology (medical) ,Internal medicine ,Atrial Fibrillation ,Catheter Ablation ,Tachycardia, Ventricular ,Cardiology ,Humans ,Medicine ,University medical ,General hospital ,Cardiology and Cardiovascular Medicine ,business ,Humanities - Abstract
Venice Chart International Consensus Document on Ventricular Tachycardia/Ventricular Fibrillation Ablation ANDREA NATALE, M.D.,∗ ANTONIO RAVIELE, M.D.,† AMIN AL-AHMAD, M.D.,‡ OTTAVIO ALFIERI, M.D.,¶ ETIENNE ALIOT, M.D.,∗∗ JESUS ALMENDRAL, M.D.,†† GUNTER BREITHARDT, M.D.,‡‡ JOSEP BRUGADA, M.D.,¶¶ HUGH CALKINS, M.D.,∗∗∗ DAVID CALLANS, M.D.,††† RICCARDO CAPPATO, M.D.,‡‡‡ JOHN A. CAMM, M.D.,¶¶¶ PAOLO DELLA BELLA, M.D.,∗∗∗∗ GERARD M. GUIRAUDON, M.D.,†††† MICHEL HAISSAGUERRE, M.D.,‡‡‡‡ GERHARD HINDRICKS, M.D.,¶¶¶¶ SIEW YEN HO, M.D.,∗∗∗∗∗ KARL H. KUCK, M.D.,††††† FRANCIS MARCHLINSKI, M.D.,‡‡‡‡‡ DOUGLAS L. PACKER, M.D.,¶¶¶¶¶ ERIC N. PRYSTOWSKY, M.D.,∗∗∗∗∗∗ VIVEK Y. REDDY, M.D.,†††††† JEREMY N. RUSKIN, M.D.,‡‡‡‡‡‡ MAURICIO SCANAVACCA, M.D.,¶¶¶¶¶¶ KALYANAM SHIVKUMAR, M.D.,∗∗∗∗∗∗∗ KYOKO SOEJIMA, M.D.,††††††† WILLIAM J. STEVENSON, M.D.,‡‡‡‡‡‡‡ SAKIS THEMISTOCLAKIS, M.D.,¶¶¶¶¶¶¶ ATUL VERMA, M.D.,∗∗∗∗∗∗∗∗ and DAVID WILBER, M.D.,†††††††† for the Venice Chart members From the ∗Texas Cardiac Arrhythmia Institute, St. David’s Medical Center, Austin, TX, USA; †Cardiovascular Department, Ospedale dell’Angelo, Mestre-Venice, Italy; ‡Cardiac Arrhythmia Service, Stanford University Medical School, Stanford, USA; ¶Department of Cardiac Surgery, Ospedale San Raffaele, Milan, Italy; ∗∗Department of Cardio-Vascular Diseases, CHU de Nancy, Hopital de Brabois, Vandoeuvre-les-Nancy, France; ††Division of Cardiology, Hospital General Gregorio Maranon, Madrid, Spain; ‡‡Department of Cardiology and Angiology, University Hospital of Munster, Munster, Germany; ¶¶Thorax Institute-Cardiology, Hospital Clinic, University of Barcelona, Barcelona, Spain; ∗∗∗Department of Cardiology, The Johns Hopkins Hospital, Baltimore, MD, USA; †††Department of Medicine, Section of Cardiovascular Disease, Hospital of the University of Pennsylvania, Philadelphia, PA, USA; ‡‡‡Department of Electrophysiology, Policlinico San Donato, San Donato Milanese, Italy; ¶¶¶Cardiac and Vascular Sciences, St. George’s Hospital Medical School, London, UK; ∗∗∗∗Cardiology Division, Centro Cardiologico Monzino, Milan, Italy; ††††Cardiac Surgery, University of Western Ontario, London, Canada; ‡‡‡‡Hopital Cardiologique du Haut Leveque, Bordeaux, France; ¶¶¶¶Heart Center, Department of Cardiology, University of Leipzig, Leipzig, Germany; ∗∗∗∗∗Cardiac Morphology Unit, Royal Brompton Hospital, London and Imperial College, London, UK; †††††Department of Cardiology, Asklepios Klinik St. Georg, Hamburg, Germany; ‡‡‡‡‡Department of Medicine, Section of Cardiovascular Disease, University of Pennsylvania, Philadelphia, PA, USA; ¶¶¶¶¶Cardiac Translational and Electrophysiology Laboratory, Saint Mary’s Hospital Complex, Mayo Clinic Foundation, Rochester, NY, USA; ∗∗∗∗∗∗The Care Group, Indianapolis, IN, USA; ††††††Cardiac Arrhythmia Service, Miller School of Medicine, University of Miami, Miami, USA; ‡‡‡‡‡‡Arrhythmia Service, Massachusetts General Hospital, Boston, MA, USA; ¶¶¶¶¶¶Heart Institute, University of San Paulo Medical School, San Paulo, Brazil; ∗∗∗∗∗∗∗Cardiac Arrhythmia Center, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA; †††††††Cardiovascular Division, University of Miami Hospital, Miami USA; ‡‡‡‡‡‡‡Cardiovascular Division, Brigham and Women’s Hospital, Boston, MA, USA; ¶¶¶¶¶¶¶Cardiovascular Department, Ospedale dell’Angelo, Mestre-Venice, Italy; ∗∗∗∗∗∗∗∗Cardiology, Southlake Regional Health Center, Toronto, Canada; and ††††††††Department of Cardiology, Loyola University Medical Center, Chicago, IL, USA
- Published
- 2010
122. A Bold New Era of Collaboration: JACC and JACC Clinical Electrophysiology Unite.
- Author
-
Shivkumar K and Krumholz HM
- Published
- 2024
- Full Text
- View/download PDF
123. The Rebirth of Intraoperative Electrophysiological Mapping for Complex Congenital Heart Disease.
- Author
-
Moore JP and Shivkumar K
- Abstract
Competing Interests: Funding Support and Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
- Published
- 2024
- Full Text
- View/download PDF
124. Comparative specialization of intrinsic cardiac neurons in humans, mice and pigs.
- Author
-
Tompkins JD, Hoover DB, Havton LA, Patel JC, Cho Y, Smith EH, Biscola NP, Ajijola OA, Shivkumar K, and Ardell JL
- Abstract
Intrinsic cardiac neurons (ICNs) play a crucial role in the proper functioning of the heart; yet a paucity of data pertaining to human ICNs exist. We took a multidisciplinary approach to complete a detailed cellular comparison of the structure and function of ICNs from mice, pigs and humans. Immunohistochemistry of whole and sectioned ganglia, transmission electron microscopy, intracellular microelectrode recording and dye filling for quantitative morphometry were used to define the neurophysiology, histochemistry and ultrastructure of these neurons across species. The densely packed, smaller ICNs of mouse lacked dendrites, formed axosomatic connections and had high synaptic efficacy constituting an obligatory synapse. At pig ICNs, a convergence of subthreshold cholinergic inputs onto extensive dendritic arbors supported greater summation and integration of synaptic input. Human ICNs were tonically firing, with synaptic stimulation evoking large suprathreshold EPSPs like mouse, and subthreshold potentials like pig. Ultrastructural examination of synaptic terminals revealed conserved architecture, yet small clear vesicles were larger in pigs and humans. The presence and localization of ganglionic neuropeptides was distinct, with abundant vasoactive intestinal polypeptide observed in human but not pig or mouse ganglia, and little substance P or calcitonin gene-related peptide in pig ganglia. Action potential waveforms were similar, but human ICNs had larger after-hyperpolarizations. Intrinsic excitability differed; 95% of human neurons were tonic, all pig neurons were phasic, and both phasic and tonic phenotypes were observed in mouse. In combination, this publicly accessible, multimodal atlas of ICNs from mice, pigs and humans identifies similarities and differences in the evolution of ICNs. KEY POINTS: Intrinsic cardiac neurons (ICNs) are essential to the regulation of cardiac function. We investigated the neurochemistry, morphology, ultrastructure, membrane physiology and synaptic transmission of ICNs from donated human hearts in parallel with identical studies of ICNs from mice and pigs to create a publicly accessible cellular atlas detailing the structure and function of these neurons across species. In addition to presenting foundational data on human ICNs, this comparative study identifies both conserved and derived attributes of these neurons within mammals. The findings have significant implications for understanding the regulation of cardiac autonomic function in humans and may greatly influence strategies for neuromodulation in conditions such as atrial fibrillation and heart failure., (© 2024 The Author(s). The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.)
- Published
- 2024
- Full Text
- View/download PDF
125. Prevalence of frequent premature ventricular contractions and left-ventricular systolic dysfunction in patients receiving Holter monitoring.
- Author
-
Torrado J, Sima A, Comstuck C, Kaszala K, Tan A, Koneru J, Frankel DS, Marchlinski F, Kowalski M, Sharma P, Gerstenfeld EP, Vaseghi M, Shivkumar K, Malhotra R, Morillo C, Ellenbogen KA, and Huizar JF
- Abstract
Background: Premature ventricular contractions (PVCs) are frequently observed with left ventricular (LV) systolic dysfunction, although the prevalence of these associated conditions in the general population remains unknown., Objective: We sought to understand the prevalence of frequent PVCs (defined PVCs > 5%) and high burden PVCs (defined PVCs > 10%) and LV systolic dysfunction in patients receiving ambulatory Holter monitors (HM)., Methods: A prospective multicenter (eight US medical centers) cross-sectional study collected demographic and PVC burden data from consecutive patients undergoing 24-h, 48-h, and 14-day HM (July 2018-June 2020). Left ventricle ejection fraction (LVEF) data was collected if obtained within 6 months of HM. Four PVC burden groups were analyzed (<1%, 1%-5%, 5.1%-10%, and >10% burden) and stratified by normal LVEF (≥50%) or presence LVEF < 50%., Results: The prevalence of PVC burden of 5.1%-10% and >10% was 4% and 5%, respectively in the population undergoing HM (n = 6529). Age was significantly different between PVC groups (p < .001). In those with LVEF assessment (n = 3713), the prevalence of LVEF < 50% and both LVEF < 50% and PVC > 5% was 16.4% and 4.2%, respectively. The prevalence of PVC > 5% and PVC > 10% in patients with LVEF < 50% was 26% and 16%, respectively. PVC > 5% were more prevalent in older, male, and Caucasians (p < .001). Females had a lower prevalence of PVC > 5% than males (6% vs. 11%; p < .001), but not among those with LVEF < 50% (24% vs. 26%, p = .10)., Conclusion: PVC > 5% and PVC > 10% and LVEF < 50% are prevalent in patients undergoing HM. PVC > 5% are associated with older age. Females have a lower prevalence of PVC > 5% than males but similar combined PVC > 5% and LVEF < 50%., Clinicaltrial: gov identifier: NCT03228823., (© 2024 The Author(s). Journal of Cardiovascular Electrophysiology published by Wiley Periodicals LLC.)
- Published
- 2024
- Full Text
- View/download PDF
126. Idiopathic Ventricular Fibrillation: Truly Idiopathic or Are We Missing Occult Pathology?
- Author
-
Do DH and Shivkumar K
- Subjects
- Humans, Electrocardiography, Male, Female, Ventricular Fibrillation physiopathology
- Abstract
Competing Interests: Funding Support and Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
- Published
- 2024
- Full Text
- View/download PDF
127. Towards spatially selective efferent neuromodulation: anatomical and functional organization of cardiac fibres in the porcine cervical vagus nerve.
- Author
-
Thompson N, Ravagli E, Mastitskaya S, Challita R, Hadaya J, Iacoviello F, Idil AS, Shearing PR, Ajijola OA, Ardell JL, Shivkumar K, Holder D, and Aristovich K
- Abstract
Spatially selective vagus nerve stimulation (sVNS) offers a promising approach for addressing heart disease with enhanced precision. Despite its therapeutic potential, VNS is limited by off-target effects and the need for time-consuming titration. Our research aimed to determine the spatial organization of cardiac afferent and efferent fibres within the vagus nerve of pigs to achieve targeted neuromodulation. Using trial-and-error sVNS in vivo and ex vivo micro-computed tomography fascicle tracing, we found significant spatial separation between cardiac afferent and cardiac efferent fibres at the mid-cervical level and they were localized on average on opposite sides of the nerve cross-section. This was consistent between both in vivo and ex vivo methods. Specifically, cardiac afferent fibres were located near pulmonary fibres, consistent with findings of cardiopulmonary convergent circuits and, notably, cardiac efferent fascicles were exclusive. These cardiac efferent regions were located in close proximity to the recurrent laryngeal regions. This is consistent with the roughly equitable spread across the nerve of the afferent and efferent fibres. Our study demonstrated that targeted neuromodulation via sVNS could achieve scalable heart rate decreases without eliciting cardiac afferent-related reflexes; this is desirable for reducing sympathetic overactivation associated with heart disease. These findings indicate that understanding the spatial organization of cardiac-related fibres within the vagus nerve can lead to more precise and effective VNS therapy, minimizing off-target effects and potentially mitigating the need for titration. KEY POINTS: Spatially selective vagus nerve stimulation (sVNS) presents a promising approach for addressing chronic heart disease with enhanced precision. Our study reveals significant spatial separation between cardiac afferent and efferent fibres in the vagus nerve, particularly at the mid-cervical level. Utilizing trial-and-error sVNS in vivo and micro-computed tomography fascicle tracing, we demonstrate the potential for targeted neuromodulation, achieving therapeutic effects such as scalable heart rate decrease without stimulating cardiac afferent-related reflexes. This spatial understanding opens avenues for more effective VNS therapy, minimizing off-target effects and potentially eliminating the need for titration, thereby expediting therapeutic outcomes in myocardial infarction and related conditions., (© 2024 The Author(s). The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.)
- Published
- 2024
- Full Text
- View/download PDF
128. Direct Intraoperative Conduction System Mapping for Cardiac Septation in Congenital Heart Disease.
- Author
-
Moore JP, Shivkumar K, Perens G, and Van Arsdell G
- Subjects
- Humans, Heart Conduction System physiopathology, Heart Conduction System surgery, Heart Septum diagnostic imaging, Heart Septum physiopathology, Heart Septum surgery, Heart Defects, Congenital surgery, Heart Defects, Congenital physiopathology
- Abstract
Competing Interests: Funding Support and Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
- Published
- 2024
- Full Text
- View/download PDF
129. Procedural and Intermediate-term Results of the Electroanatomical-guided Cardioneuroablation for the Treatment of Supra-Hisian Second- or Advanced-degree Atrioventricular Block: the PIRECNA multicentre registry.
- Author
-
Aksu T, Piotrowski R, Tung R, De Potter T, Markman TM, du Fay de Lavallaz J, Rekvava R, Alyesh D, Joza JE, Badertscher P, Do DH, Bradfield JS, Upadhyay G, Sood N, Sharma PS, Guler TE, Gul EE, Kumar V, Koektuerk B, Dal Forno ARJ, Woods CE, Rav-Acha M, Valeriano C, Enriquez A, Sundaram S, Glikson M, d'Avila A, Shivkumar K, Kulakowski P, and Huang HD
- Subjects
- Humans, Male, Female, Retrospective Studies, Aged, Middle Aged, Treatment Outcome, Catheter Ablation methods, Time Factors, Vagus Nerve Stimulation methods, Electrophysiologic Techniques, Cardiac, Syncope etiology, Recurrence, Atrioventricular Node surgery, Atrioventricular Node physiopathology, Registries, Atrioventricular Block physiopathology, Atrioventricular Block therapy, Atrioventricular Block surgery
- Abstract
Aims: Prior case series showed promising results for cardioneuroablation in patients with vagally induced atrioventricular blocks (VAVBs). We aimed to examine the acute procedural characteristics and intermediate-term outcomes of electroanatomical-guided cardioneuroablation (EACNA) in patients with VAVB., Methods and Results: This international multicentre retrospective registry included data collected from 20 centres. Patients presenting with symptomatic paroxysmal or persistent VAVB were included in the study. All patients underwent EACNA. Procedural success was defined by the acute reversal of atrioventricular blocks (AVBs) and complete abolition of atropine response. The primary outcome was occurrence of syncope and daytime second- or advanced-degree AVB on serial prolonged electrocardiogram monitoring during follow-up. A total of 130 patients underwent EACNA. Acute procedural success was achieved in 96.2% of the cases. During a median follow-up of 300 days (150, 496), the primary outcome occurred in 17/125 (14%) cases with acute procedural success (recurrence of AVB in 9 and new syncope in 8 cases). Operator experience and use of extracardiac vagal stimulation were similar for patients with and without primary outcomes. A history of atrial fibrillation, hypertension, and coronary artery disease was associated with a higher primary outcome occurrence. Only four patients with primary outcome required pacemaker placement during follow-up., Conclusion: This is the largest multicentre study demonstrating the feasibility of EACNA with encouraging intermediate-term outcomes in selected patients with VAVB. Studies investigating the effect on burden of daytime symptoms caused by the AVB are required to confirm these findings., Competing Interests: Conflict of interest: none declared., (© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.)
- Published
- 2024
- Full Text
- View/download PDF
130. Underexpansion and Neoleaflet Bending Caused by Transcatheter Valve-in-Valve Mismatch.
- Author
-
Sato T, Moussa ID, Ajijola OA, Shivkumar K, and Mori S
- Subjects
- Aged, Humans, Aortic Valve Stenosis surgery, Aortic Valve Stenosis diagnostic imaging, Aortic Valve Stenosis physiopathology, Hemodynamics, Prosthesis Failure, Severity of Illness Index, Transcatheter Aortic Valve Replacement instrumentation, Transcatheter Aortic Valve Replacement adverse effects, Treatment Outcome, Aortic Valve surgery, Aortic Valve diagnostic imaging, Aortic Valve physiopathology, Cardiac Catheterization instrumentation, Cardiac Catheterization adverse effects, Heart Valve Prosthesis, Heart Valve Prosthesis Implantation instrumentation, Heart Valve Prosthesis Implantation adverse effects, Prosthesis Design
- Abstract
Competing Interests: Funding Support and Author Disclosures This work was supported by the National Institutes of Health grants OT2OD023848 and P01 HL164311 to Dr Shivkumar and from the UCLA Amara-Yad Project. The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
- Published
- 2024
- Full Text
- View/download PDF
131. Rate of Change of Initial Intrinsicoid Deflection Predicts Endocardial Versus Epicardial Ventricular Tachycardia.
- Author
-
Prisco AR, Hayase J, Olson M, Brigham RC, Ramirez DA, Iaizzo PA, Shivkumar K, Bradfield J, and Tholakanahalli VN
- Subjects
- Humans, Male, Female, Middle Aged, Aged, Heart Conduction System physiopathology, Cardiomyopathies physiopathology, Adult, Catheter Ablation, Sensitivity and Specificity, Tachycardia, Ventricular physiopathology, Tachycardia, Ventricular diagnosis, Endocardium physiopathology, Electrocardiography, Pericardium physiopathology
- Abstract
Background: Assessment of origin of ventricular tachycardias (VTs) arising from epicardial vs endocardial sites are largely challenged by the available criteria and etiology of cardiomyopathy. Current electrocardiographic (ECG) criteria based on 12-lead ECG have varying sensitivity and specificity based on site of origin and etiology of cardiomyopathy., Objectives: This study sought to test the hypothesis that epicardial VT has a slower initial rate of depolarization than endocardial VT., Methods: We developed a method that takes advantage of the fact that electrical conduction is faster through the cardiac conduction system than the myocardium, and that the conduction system is primarily an endocardial structure. The technique calculated the rate of change in the initial VT depolarization from a signal-averaged 12-lead ECG. We hypothesized that the rate of change of depolarization in endocardial VT would be faster than epicardial. We assessed by applying this technique among 26 patients with VT in nonischemic cardiomyopathy patients., Results: When comparing patients with VTs ablated using epicardial and endocardial approaches, the rate of change of depolarization was found to be significantly slower in epicardial (6.3 ± 3.1 mV/s vs 11.4 ± 3.7 mV/s; P < 0.05). Statistical significance was found when averaging all 12 ECG leads and the limb leads, but not the precordial leads. Follow up analysis by calculation of a receiver-operating characteristic curve demonstrated that this analysis provides a strong prediction if a VT is epicardial in origin (AUC range 0.72-0.88). Slower rate of change of depolarization had high sensitivity and specificity for prediction of epicardial VT., Conclusions: This study demonstrates that depolarization rate analysis is a potential technique to predict if a VT is epicardial in nature., Competing Interests: Funding Support and Author Disclosures This work was supported in part by the University of Minnesota’s Medical School Academic Investment Education Program grant and the Institute for Engineering in Medicine. Dr Prisco is funded by the National Institutes of Health T32 HL144472. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose., (Copyright © 2024 American College of Cardiology Foundation. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
132. Osteopontin stabilization and collagen containment slows amorphous calcium phosphate transformation during human aortic valve leaflet calcification.
- Author
-
Sivaguru M, Mori S, Fouke KW, Ajijola OA, Shivkumar K, Samuel AZ, Bhargava R, and Fouke BW
- Subjects
- Humans, Durapatite metabolism, Durapatite chemistry, Aortic Valve Stenosis metabolism, Aortic Valve Stenosis pathology, Cholesterol metabolism, Calcium Phosphates metabolism, Aortic Valve metabolism, Aortic Valve pathology, Osteopontin metabolism, Calcinosis metabolism, Calcinosis prevention & control, Collagen metabolism
- Abstract
Calcification of aortic valve leaflets is a growing mortality threat for the 18 million human lives claimed globally each year by heart disease. Extensive research has focused on the cellular and molecular pathophysiology associated with calcification, yet the detailed composition, structure, distribution and etiological history of mineral deposition remains unknown. Here transdisciplinary geology, biology and medicine (GeoBioMed) approaches prove that leaflet calcification is driven by amorphous calcium phosphate (ACP), ACP at the threshold of transformation toward hydroxyapatite (HAP) and cholesterol biomineralization. A paragenetic sequence of events is observed that includes: (1) original formation of unaltered leaflet tissues: (2) individual and coalescing 100's nm- to 1 μm-scale ACP spherules and cholesterol crystals biomineralizing collagen fibers and smooth muscle cell myofilaments; (3) osteopontin coatings that stabilize ACP and collagen containment of nodules preventing exposure to the solution chemistry and water content of pumping blood, which combine to slow transformation to HAP; (4) mm-scale nodule growth via ACP spherule coalescence, diagenetic incorporation of altered collagen and aggregation with other ACP nodules; and (5) leaflet diastole and systole flexure causing nodules to twist, fold their encasing collagen fibers and increase stiffness. These in vivo mechanisms combine to slow leaflet calcification and establish previously unexplored hypotheses for testing novel drug therapies and clinical interventions as viable alternatives to current reliance on surgical/percutaneous valve implants., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
133. Multidetector Computed Tomography Assessment of Anatomical Ventricular Tachycardia Isthmuses in Repaired Tetralogy of Fallot.
- Author
-
Moore JP, Su J, Shannon KM, Perens GS, Newlon C, Bradfield JS, and Shivkumar K
- Subjects
- Humans, Male, Female, Adult, Middle Aged, Young Adult, Catheter Ablation, Tachycardia, Ventricular physiopathology, Tachycardia, Ventricular diagnostic imaging, Tachycardia, Ventricular surgery, Tetralogy of Fallot surgery, Tetralogy of Fallot diagnostic imaging, Tetralogy of Fallot physiopathology, Multidetector Computed Tomography
- Abstract
Background: Tetralogy of Fallot (TOF) is associated with risk for sustained monomorphic ventricular tachycardia (VT). Preemptive electrophysiology study before transcatheter pulmonary valve placement is increasing, but the value of MDCT for anatomical VT isthmus assessment is unknown., Objectives: The purpose of this study was to determine the impact of multidetector computed tomography (MDCT) in the evaluation of sustained monomorphic VT for repaired TOF., Methods: Consecutive pre-transcatheter pulmonary valve MDCT studies were identified, and anatomical isthmus dimensions were measured. For a subset of patients with preemptive electrophysiology study, MDCT features were compared with electroanatomical maps., Results: A total of 61 repaired TOFs with MDCT were identified (mean 35 ± 14 years, 58% men) with MDCT electroanatomical map pairs in 35 (57%). Calcification corresponding to patch material was present in 46 (75%) and was used to measure anatomical VT isthmuses. MDCT wall thickness correlated positively with number of ablation lesions and varied with functional isthmus properties (blocked isthmus 2.6 mm [Q1, Q3: 2.1, 4.0 mm], slow conduction 4.8 mm [Q1, Q3: 3.3, 6.0 mm], and normal conduction 5.6 mm [Q1, Q3: 3.9, 8.3 mm]; P < 0.001). A large conal branch was present in 6 (10%) and a major coronary anomaly was discovered in 3 (5%). Median ablation lesion distance was closer to the right vs the left coronary artery (10 mm vs 15 mm; P = 0.01) with lesion-to-coronary distance <5 mm in 3 patients., Conclusions: MDCT identifies anatomical structures relevant to catheter ablation for repaired TOF. Wall thickness at commonly targeted anatomical VT isthmuses is associated with functional isthmus properties and increased thermal energy delivery., Competing Interests: Funding Support and Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose., (Published by Elsevier Inc.)
- Published
- 2024
- Full Text
- View/download PDF
134. Understanding Cardiac Anatomy and Imaging to Improve Safety of Procedures: The Interleaflet Triangle.
- Author
-
Sato T, Bradfield JS, Shivkumar K, and Mori S
- Subjects
- Humans, Patient Safety, Heart anatomy & histology, Heart diagnostic imaging
- Abstract
Competing Interests: Funding Support and Author Disclosures This work was made possible by support from NIH grants OT2OD023848 & P01 HL164311 to Dr Shivkumar and the UCLA Amara-Yad Project. The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
- Published
- 2024
- Full Text
- View/download PDF
135. Cardioneuroablation for the management of patients with recurrent vasovagal syncope and symptomatic bradyarrhythmias: the CNA-FWRD Registry.
- Author
-
Aksu T, Tung R, De Potter T, Markman TM, Santangeli P, du Fay de Lavallaz J, Winterfield JR, Baykaner T, Alyesh D, Joza JE, Gopinathannair R, Badertscher P, Do DH, Hussein A, Osorio J, Dewland T, Perino A, Rodgers AJ, DeSimone C, Alfie A, Atwater BD, Singh D, Kumar K, Salcedo J, Bradfield JS, Upadhyay G, Sood N, Sharma PS, Gautam S, Kumar V, Forno ARJD, Woods CE, Rav-Acha M, Valeriano C, Kapur S, Enriquez A, Sundaram S, Glikson M, Gerstenfeld E, Piccini J, Tzou WS, Sauer W, d'Avila A, Shivkumar K, and Huang HD
- Abstract
Background: Cardioneuroablation has been emerging as a potential treatment alternative in appropriately selected patients with cardioinhibitory vasovagal syncope (VVS) and functional AV block (AVB). However the majority of available evidence has been derived from retrospective cohort studies performed by experienced operators., Methods: The Cardioneuroablation for the Management of Patients with Recurrent Vasovagal Syncope and Symptomatic Bradyarrhythmias (CNA-FWRD) Registry is a multicenter prospective registry with cross-over design evaluating acute and long-term outcomes of VVS and AVB patients treated by conservative therapy and CNA., Results: The study is a prospective observational registry with cross-over design for analysis of outcomes between a control group (i.e., behavioral and medical therapy only) and intervention group (Cardioneuroablation). Primary and secondary outcomes will only be assessed after enrollment in the registry. The follow-up period will be 3 years after enrollment., Conclusions: There remains a lack of prospective multicentered data for long-term outcomes comparing conservative therapy to radiofrequency CNA procedures particularly for key outcomes including recurrence of syncope, AV block, durable impact of disruption of the autonomic nervous system, and long-term complications after CNA. The CNA-FWRD registry has the potential to help fill this information gap., (© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
136. The vagus nerve in cardiovascular physiology and pathophysiology: From evolutionary insights to clinical medicine.
- Author
-
Rajendran PS, Hadaya J, Khalsa SS, Yu C, Chang R, and Shivkumar K
- Subjects
- Humans, Vagus Nerve physiology, Heart, Heart Rate physiology, Heart Diseases, Clinical Medicine
- Abstract
The parasympathetic nervous system via the vagus nerve exerts profound influence over the heart. Together with the sympathetic nervous system, the parasympathetic nervous system is responsible for fine-tuned regulation of all aspects of cardiovascular function, including heart rate, rhythm, contractility, and blood pressure. In this review, we highlight vagal efferent and afferent innervation of the heart, with a focus on insights from comparative biology and advances in understanding the molecular and genetic diversity of vagal neurons, as well as interoception, parasympathetic dysfunction in heart disease, and the therapeutic potential of targeting the parasympathetic nervous system in cardiovascular disease., (Copyright © 2023 Elsevier Ltd. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
137. Stellate ganglion blockade for the management of ventricular arrhythmia storm.
- Author
-
Malik V and Shivkumar K
- Subjects
- Humans, Stellate Ganglion, Arrhythmias, Cardiac drug therapy, Ventricular Fibrillation, Autonomic Nerve Block, Tachycardia, Ventricular drug therapy
- Published
- 2024
- Full Text
- View/download PDF
138. Anatomical and functional organization of cardiac fibers in the porcine cervical vagus nerve allows spatially selective efferent neuromodulation.
- Author
-
Thompson N, Ravagli E, Mastitskaya S, Challita R, Hadaya J, Iacoviello F, Shah Idil A, Shearing PR, Ajijola OA, Ardell JL, Shivkumar K, Holder D, and Aristovich K
- Abstract
Cardiac disease progression reflects the dynamic interaction between adversely remodeled neurohumoral control systems and an abnormal cardiac substrate. Vagal nerve stimulation (VNS) is an attractive neuromodulatory option to dampen this dynamic interaction; however, it is limited by off-target effects. Spatially-selective VNS (sVNS) offers a promising solution to induce cardioprotection while mitigating off-target effects by specifically targeting pre-ganglionic parasympathetic efferent cardiac fibers. This approach also has the potential to enhance therapeutic outcomes by eliminating time-consuming titration required for optimal VNS. Recent studies have demonstrated the independent modulation of breathing rate, heart rate, and laryngeal contraction through sVNS. However, the spatial organization of afferent and efferent cardiac-related fibers within the vagus nerve remains unexplored. By using trial-and-error sVNS in vivo in combination with ex vivo micro-computed tomography fascicle tracing, we show the significant spatial separation of cardiac afferent and efferent fibers (179±55° SD microCT, p<0.05 and 200±137° SD, p<0.05 sVNS - degrees of separation across a cross-section of nerve) at the mid-cervical level. We also show that cardiac afferent fibers are located in proximity to pulmonary fibers consistent with recent findings of cardiopulmonary convergent neurons and circuits. We demonstrate the ability of sVNS to selectively elicit desired scalable heart rate decrease without stimulating afferent-related reflexes. By elucidating the spatial organization of cardiac-related fibers within the vagus nerve, our findings pave the way for more targeted neuromodulation, thereby reducing off-target effects and eliminating the need for titration. This, in turn, will enhance the precision and efficacy of VNS therapy in treating cardiac pathology, allowing for improved therapeutic efficacy., Competing Interests: Conflict of Interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
- Published
- 2024
- Full Text
- View/download PDF
139. Long-Term Outcomes of Cardiac Resynchronization Therapy in Patients With Repaired Tetralogy of Fallot: A Multicenter Study.
- Author
-
Ramdat Misier NL, Moore JP, Nguyen HH, Lloyd MS, Dubin AM, Mah DY, Czosek RJ, Khairy P, Chang PM, Nielsen JC, Aydin A, Pilcher TA, O'Leary ET, Shivkumar K, and de Groot NMS
- Subjects
- Adult, Humans, Retrospective Studies, Stroke Volume, Treatment Outcome, Ventricular Function, Left, Middle Aged, Cardiac Resynchronization Therapy adverse effects, Heart Defects, Congenital therapy, Heart Failure diagnosis, Heart Failure therapy, Heart Failure etiology, Tetralogy of Fallot surgery
- Abstract
Background: A growing number of patients with tetralogy of Fallot develop left ventricular systolic dysfunction and heart failure, in addition to right ventricular dysfunction. Although cardiac resynchronization therapy (CRT) is an established treatment option, the effect of CRT in this population is still not well defined. This study aimed to investigate the early and late efficacy, survival, and safety of CRT in patients with tetralogy of Fallot., Methods: Data were analyzed from an observational, retrospective, multicenter cohort, initiated jointly by the Pediatric and Congenital Electrophysiology Society and the International Society of Adult Congenital Heart Disease. Twelve centers contributed baseline and longitudinal data, including vital status, left ventricular ejection fraction (LVEF), QRS duration, and NYHA functional class. Outcomes were analyzed at early (3 months), intermediate (1 year), and late follow-up (≥2 years) after CRT implantation., Results: A total of 44 patients (40.3±19.2 years) with tetralogy of Fallot and CRT were enrolled. Twenty-nine (65.9%) patients had right ventricular pacing before CRT upgrade. The left ventricular ejection fraction improved from 32% [24%-44%] at baseline to 42% [32%-50%] at early follow-up ( P <0.001) and remained improved from baseline thereafter ( P ≤0.002). The QRS duration decreased from 180 [160-205] ms at baseline to 152 [133-182] ms at early follow-up ( P <0.001) and remained decreased at intermediate and late follow-up ( P ≤0.001). Patients with upgraded CRT had consistent improvement in left ventricular ejection fraction and QRS duration at each time point ( P ≤0.004). Patients had a significantly improved New York Heart Association functional class after CRT implantation at each time point compared with baseline ( P ≤0.002). The transplant-free survival rates at 3, 5, and 8 years after CRT implantation were 85%, 79%, and 73%., Conclusions: In patients with tetralogy of Fallot treated with CRT consistent improvement in QRS duration, left ventricular ejection fraction, New York Heart Association functional class, and reasonable long-term survival were observed. The findings from this multicenter study support the consideration of CRT in this unique population., Competing Interests: Disclosures None.
- Published
- 2024
- Full Text
- View/download PDF
140. Distribution and morphology of calcitonin gene-related peptide (CGRP) innervation in flat mounts of whole rat atria and ventricles.
- Author
-
Chen J, Bendowski KT, Bizanti A, Zhang Y, Ma J, Hoover DB, Gozal D, Shivkumar K, and Cheng ZJ
- Subjects
- Animals, Rats, Axons, Immunohistochemistry, Neurons, Calcitonin Gene-Related Peptide, Heart Atria
- Abstract
Calcitonin gene-related peptide (CGRP) is widely used as a marker for nociceptive afferent axons. However, the distribution of CGRP-IR axons has not been fully determined in the whole rat heart. Immunohistochemically labeled flat-mounts of the right and left atria and ventricles, and the interventricular septum (IVS) in rats for CGRP were assessed with a Zeiss imager to generate complete montages of the entire atria, ventricles, and septum, and a confocal microscope was used to acquire detailed images of selected regions. We found that 1) CGRP-IR axons extensively innervated all regions of the atrial walls including the sinoatrial node region, auricles, atrioventricular node region, superior/inferior vena cava, left pre-caval vein, and pulmonary veins. 2) CGRP-IR axons formed varicose terminals around individual neurons in some cardiac ganglia but passed through other ganglia without making appositions with cardiac neurons. 3) Varicose CGRP-IR axons innervated the walls of blood vessels. 4) CGRP-IR axons extensively innervated the right/left ventricular walls and IVS. Our data shows the rather ubiquitous distribution of CGRP-IR axons in the whole rat heart at single-cell/axon/varicosity resolution for the first time. This study lays the foundation for future studies to quantify the differences in CGRP-IR axon innervation between sexes, disease models, and species., Competing Interests: Declaration of competing interest No potential conflicts of interest were disclosed., (Copyright © 2023 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
141. Comprehensive Anatomy of the Summit of the Left Ventricle.
- Author
-
Mori S, Bradfield JS, Fukuzawa K, and Shivkumar K
- Subjects
- Humans, Electrocardiography, Heart Ventricles diagnostic imaging, Tachycardia, Ventricular
- Abstract
Competing Interests: Funding Support and Author Disclosures This work was made possible by support from National Institutes of Health grant OT2OD023848 to Dr Shivkumar. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
- Published
- 2024
- Full Text
- View/download PDF
142. Bioelectronics for neurocardiology: diagnosis and therapeutics.
- Author
-
Paterson DJ and Shivkumar K
- Published
- 2023
- Full Text
- View/download PDF
143. Cryothermal energy demonstrates shorter ablation time and lower complication rates compared with radiofrequency in surgical hybrid ablation for recurrent ventricular tachycardia.
- Author
-
Chung WH, Hayase J, Davies MJ, Do DH, Sorg JM, Ajijola OA, Buch EF, Boyle NG, Shivkumar K, and Bradfield JS
- Subjects
- Humans, Retrospective Studies, Endocardium, Pericardium surgery, Treatment Outcome, Tachycardia, Ventricular, Catheter Ablation adverse effects, Catheter Ablation methods
- Abstract
Background: Recurrent ventricular tachycardia (VT) after prior endocardial catheter ablation(s) presents challenges in the setting of prior cardiac surgery where percutaneous epicardial access may not be feasible., Objective: The purpose of this study was to compare the outcomes of cryothermal vs radiofrequency ablation in direct surgical epicardial access procedures., Methods: We performed a retrospective study of consecutive surgical epicardial VT ablation cases. Surgical cases using cryothermal vs radiofrequency ablation were analyzed and outcomes were compared., Results: Between 2009 and 2022, 43 patients underwent either a cryothermal (n = 17) or a radiofrequency (n = 26) hybrid epicardial ablation procedure with direct surgical access. Both groups were similarly matched for age, sex, etiology of VT, and comorbidities with a high burden of refractory VT despite previous endocardial and/or percutaneous epicardial ablation procedures. The surgical access site was lateral thoracotomy (76.5%) in the cryothermal ablation group compared with lateral thoracotomy (42.3%) and subxiphoid approach (38.5%) in the radiofrequency group, with the remainder in both groups performed via median sternotomy. The ablation time was significantly shorter in those undergoing cryothermal ablation vs radiofrequency ablation (11.54 ± 15.5 minutes vs 48.48 ± 23.6 minutes; P < .001). There were no complications in the cryothermal ablation group compared with 6 patients with complications in the radiofrequency group. Recurrent VT episodes and all-cause mortality were similar in both groups., Conclusion: Hybrid surgical VT ablation with cryothermal or radiofrequency energy demonstrated similar efficacy outcomes. Cryothermal ablation was more efficient and safer than radiofrequency in a surgical setting and should be considered when surgical access is required., (Copyright © 2023 Heart Rhythm Society. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
144. Are device-detected atrial high-rate episodes a risk marker for stroke?
- Author
-
Hanna P, Buch E, and Shivkumar K
- Subjects
- Humans, Risk Factors, Risk Assessment methods, Heart Rate physiology, Predictive Value of Tests, Atrial Fibrillation diagnosis, Stroke diagnosis, Stroke epidemiology
- Published
- 2023
- Full Text
- View/download PDF
145. Sinus rhythm QRS morphology reflects right ventricular activation and anatomical ventricular tachycardia isthmus conduction in repaired tetralogy of Fallot.
- Author
-
Moore JP, Shannon KM, Khairy P, Waldmann V, Bessière F, Burrows A, Su J, and Shivkumar K
- Subjects
- Humans, Male, Female, Heart Ventricles, Arrhythmias, Cardiac, Electrocardiography methods, Tetralogy of Fallot complications, Tetralogy of Fallot diagnosis, Tetralogy of Fallot surgery, Tachycardia, Ventricular diagnosis, Tachycardia, Ventricular etiology, Tachycardia, Ventricular surgery, Heart Septal Defects, Ventricular
- Abstract
Background: Patients with repaired tetralogy of Fallot (TOF) are at risk for ventricular tachycardia (VT) related to well-described anatomical isthmuses., Objective: The purpose of this study was to explore QRS morphology as an indicator of anatomical isthmus conduction., Methods: Patients with repaired TOF and complete right bundle branch block referred for transcatheter pulmonary valve replacement (PVR) or presenting with sustained VT underwent comprehensive 3-dimensional mapping in sinus rhythm. Electrocardiographic characteristics were compared to right ventricular (RV) activation and anatomical isthmus conduction properties., Results: Twenty-two patients (19 pre-pulmonary valve replacement and 3 clinical VT) underwent comprehensive 3-dimensional mapping (median 39 years; interquartile range [IQR] 27-48 years; 12 [55%] male). Septal RV activation (median 40 ms; IQR 34-46 ms) corresponded to the nadir in lead V
1 and free wall activation (median 71 ms; IQR 64-81 ms) to the transition point in the upstroke of the R' wave. Patients with isthmus block between the pulmonary annulus and the ventricular septal defect patch and between the ventricular septal defect patch and the tricuspid annulus (when present), were more likely to demonstrate lower amplitude R' waves in lead V1 (5.8 mV vs 9.4 mV; P = .005), QRS fragmentation in lead V1 (15 [94%] vs 2 [13%]; P < .001), and terminal S waves in lead aVF (15 [94%] vs 6 [40%]; P < .001) than those with intact conduction. During catheter ablation, these QRS changes developed during isthmus block., Conclusion: For patients with repaired TOF, the status of septal isthmus conduction was evident from sinus rhythm QRS morphology. Low-amplitude, fragmented R' waves in lead V1 and terminal S waves in the inferior leads were related to septal isthmus conduction abnormalities, providing a mechanistic link between RV activation and common electrocardiographic findings., (Published by Elsevier Inc.)- Published
- 2023
- Full Text
- View/download PDF
146. Understanding Cardiac Anatomy and Imaging to Improve Safety of Procedures: The Sinus Node Artery.
- Author
-
Esrailian DL, Mori S, and Shivkumar K
- Abstract
The sinus node artery can originate from either the right or the left coronary arteries, or even both, and follows a variable course. Being aware of these important variations is of clinical significance during open heart surgery and catheter ablation procedures to avoid injury to the artery., Competing Interests: This work was made possible by support from National Institutes of Health grants OT2OD023848 and P01 HL164311 to Dr Shivkumar and supported by the Amara Yad Program (https://www.uclahealth.org/medical-services/heart/arrhythmia/about-us/amara-yad-project). The authors have reported that they have no relationships relevant to the contents of this paper to disclose., (© 2023 The Authors.)
- Published
- 2023
- Full Text
- View/download PDF
147. Cardiac Conduction System Pacing: A Comprehensive Update.
- Author
-
Vijayaraman P, Chelu MG, Curila K, Dandamudi G, Herweg B, Mori S, Jastrzebski M, Sharma PS, Shivkumar K, Tung R, Upadhyay G, Vernooy K, Welter-Frost A, Whinnett Z, Zanon F, and Ellenbogen KA
- Subjects
- Humans, Bundle-Branch Block therapy, Electrocardiography, Heart Conduction System, Cardiac Conduction System Disease therapy, Bundle of His, Cardiac Resynchronization Therapy
- Abstract
The field of cardiac pacing has changed rapidly in the last several years. Since the initial description of His bundle pacing targeting the conduction system, recent advances in pacing the left bundle branch and its fascicles have evolved. The field and investigators' knowledge of conduction system pacing including relevant anatomy and physiology has advanced significantly. The aim of this review is to provide a comprehensive update on recent advances in conduction system pacing., Competing Interests: Funding Support and Author Disclosures Work on anatomy was made possible by support from National Institutes of Health grants OT2OD023848 (to Dr K Shivkumar) and from the Tawara-McAlpine Festschrift (a component of the UCLA Amara-Yad Project). Dr Vijayaraman has received honoraria, consulting fees, and research and fellowship support from Medtronic; honoraria from Biotronik and Boston Scientific; and consulting fees from Abbott; and holds a patent for an HBP delivery tool. Dr Chelu has received research support from PCORI, National Institutes of Health, Abbott, and Impulse Dynamics; and honoraria from Impulse Dynamics. Dr Curila has received consulting fees and honoraria from Medtronic, Biotronik, and Abbott; has filed U.S. patent: US11,517,243B2: “Method of electrocardiographic signal processing and apparatus for performing the method”; and is a shareholder of VDI Technologies. Dr Dandamudi has received honoraria and consulting fees from Medtronic; and served on advisory boards of Medtronic, Biotronik, and Abbott. Dr Herweg has served as a speaker and consultant for Abbott; and has received speaking fees and fellowship support from Medtronic. Dr Jastrzebski has received honoraria and consulting fees from Medtronic and Abbott. Dr Sharma has received honoraria from Medtronic; and consulting fees from Medtronic, Abbott, Biotronik, and Boston Scientific. Dr Shivkumar is a cofounder of NeuCures Inc. Dr Tung has received honoraria and consulting fees from– Abbott. Dr Upadhyay has received honoraria from and served on advisory boards for Abbott, Biotronik, Boston Scientific, Medtronic, Philips BioTel, and Zoll Medical. Dr Vernooy has received consulting fees from Biosense Webster, Philips, Medtronic, and Abbott; honoraria from Microport; and research and educational grants (paid to institution) from Philips, Abbott, Medtronic, and Biosense Webster. Dr Whinnett has received honoraria from Medtronic and Boston Scientific; and consulting fees from Medtronic and Abbott. Dr Zanon has received honoraria from Abbott, Biotronik, Boston Scientific, Medtronic, and Microport. Dr Ellenbogen has received consulting fees from Medtronic, Boston Scientific, Abbott, and Biotronik; and honoraria from Medtronic, Boston Scientific, and Biotronik. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose., (Copyright © 2023 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
148. Ischemia-induced ventricular proarrhythmia and cardiovascular autonomic dysreflexia after cardioneuroablation.
- Author
-
Chung WH, Masuyama K, Challita R, Hayase J, Mori S, Cha S, Bradfield JS, Ardell JL, Shivkumar K, and Ajijola OA
- Subjects
- Animals, Heart, Heart Ventricles, Ischemia, Swine, Ventricular Fibrillation etiology, Autonomic Dysreflexia, Tachycardia, Ventricular etiology
- Abstract
Background: Cardioneuroablation (CNA) is an attractive treatment of vasovagal syncope. Its long-term efficacy and safety remain unknown., Objective: The purpose of this study was to develop a chronic porcine model of CNA to examine the susceptibility to ventricular tachyarrhythmia (ventricular tachycardia/ventricular fibrillation [VT/VF]) and cardiac autonomic function after CNA., Methods: A percutaneous CNA model was developed by ablation of left- and right-sided ganglionated plexi (n = 5), confirmed by histology. Reproducible bilateral vagal denervation was confirmed after CNA by extracardiac vagal nerve stimulation (VNS) and histology. Chronic studies included 16 pigs randomized to CNA (n = 8) and sham ablation (n = 8, Control). After 6 weeks, animals underwent hemodynamic studies, assessment of cardiac sympathetic and parasympathetic function using sympathetic chain stimulation and direct VNS, respectively, and proarrhythmic potential after left anterior descending (LAD) coronary artery ligation., Results: After CNA, extracardiac VNS responses remained abolished for 6 weeks despite ganglia remaining in ablated ganglionated plexi. In the CNA group, direct VNS resulted in paradoxical increases in blood pressure, but not in sham-ablated animals (CNA group vs sham group: 8.36% ± 7.0% vs -4.83% ± 8.7%, respectively; P = .009). Left sympathetic chain stimulation (8 Hz) induced significant corrected QT interval prolongation in the CNA group vs the sham group (11.23% ± 4.0% vs 1.49% ± 4.0%, respectively; P < .001). VT/VF after LAD ligation was more prevalent and occurred earlier in the CNA group than in the control group (61.44 ± 73.7 seconds vs 245.11 ± 104.0 seconds, respectively; P = .002)., Conclusion: Cardiac vagal denervation is maintained long-term after CNA in a porcine model. However, chronic CNA was associated with cardiovascular dysreflexia, diminished cardioprotective effects of cardiac vagal tone, and increased susceptibility to VT/VF in ischemia. These potential long-term negative effects of CNA suggest the need for rigorous clinical studies on CNA., (Copyright © 2023 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
149. Sympathetic innervation of the supraclavicular brown adipose tissue: A detailed anatomical study.
- Author
-
Mori S, Beyer RS, Bernardes de Souza B, Sorg JM, Hoover DB, Sacks HS, Fishbein MC, Chang G, Peacock WJ, St John MA, Law J, Symonds ME, Ajijola OA, Shivkumar K, and Srikanthan P
- Subjects
- Humans, Adiposity, Thermogenesis physiology, Cadaver, Glucose metabolism, Adipose Tissue, Brown metabolism, Obesity metabolism
- Abstract
Background: The supraclavicular fossa is the dominant location for human brown adipose tissue (BAT). Activation of BAT promotes non-shivering thermogenesis by utilization of glucose and free fatty acids and has been the focus of pharmacological and non-pharmacological approaches for modulation in order to improve body weight and glucose homeostasis. Sympathetic neural control of supraclavicular BAT has received much attention, but its innervation has not been extensively investigated in humans., Methods: Dissection of the cervical region in human cadavers was performed to find the distribution of sympathetic nerve branches to supraclavicular fat pad. Furthermore, proximal segments of the 4th cervical nerve were evaluated histologically to assess its sympathetic components., Results: Nerve branches terminating in supraclavicular fat pad were identified in all dissections, including those from the 3rd and 4th cervical nerves and from the cervical sympathetic plexus. Histology of the proximal segments of the 4th cervical nerves confirmed tyrosine hydroxylase positive thin nerve fibers in all fascicles with either a scattered or clustered distribution pattern. The scattered pattern was more predominant than the clustered pattern (80% vs. 20%) across cadavers. These sympathetic nerve fibers occupied only 2.48% of the nerve cross sectional area on average., Conclusions: Human sympathetic nerves use multiple pathways to innervate the supraclavicular fat pad. The present finding serves as a framework for future clinical approaches to activate human BAT in the supraclavicular region., Competing Interests: The authors have declared that no competing interests exist., (Copyright: © 2023 Mori et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
- Published
- 2023
- Full Text
- View/download PDF
150. Rationale and Design of the Multicenter Catheter Ablation of Ventricular Tachycardia Before Transcatheter Pulmonary Valve Replacement in Repaired Tetralogy of Fallot Study.
- Author
-
Moore JP, Aboulhosn JA, Zeppenfeld K, Waldmann V, Bessière F, Blom NA, Combes N, Fish FA, McLeod CJ, Kanter RJ, Tan W, Patel N, von Alvensleben JC, Kamp A, Lloyd MS, Anderson CC, Tan RB, Mariucci E, Levi DS, Salem M, Shivkumar K, and Khairy P
- Subjects
- Humans, Arrhythmias, Cardiac, Treatment Outcome, Tetralogy of Fallot complications, Tetralogy of Fallot surgery, Pulmonary Valve surgery, Tachycardia, Ventricular, Pulmonary Valve Insufficiency surgery, Catheter Ablation adverse effects, Heart Valve Prosthesis Implantation adverse effects
- Abstract
Patients with repaired tetralogy of Fallot are at elevated risk for ventricular arrhythmia and sudden cardiac death. Over the past decade, the pathogenesis and natural history of ventricular tachycardia has become increasingly understood, and catheter ablation has emerged as an effective treatment modality. Concurrently, there has been great progress in the development of a versatile array of transcatheter valves that can be placed in the native right ventricular outflow tract for the treatment of long-standing pulmonary regurgitation. Although such valve platforms may eliminate the need for repeat cardiac operations, they may also impede catheter access to the myocardial substrates responsible for sustained macro-reentrant ventricular tachycardia. This manuscript provides the rationale and design of a recently devised multicenter study that will examine the clinical outcomes of a uniform, preemptive strategy to eliminate ventricular tachycardia substrates before transcatheter pulmonary valve implantation in patients with tetralogy of Fallot., Competing Interests: Declaration of Competing Interest Drs. Aboulhosn and Levi report a relation with Edwards Lifesciences Corp. that includes consulting or advisory and with Medtronic Inc. that includes consulting or advisory. The remaining authors have no competing interests to declare., (Published by Elsevier Inc.)
- Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.